Atlas Venture Associates Ix, LLC Spero Therapeutics, Inc. Transaction History
Atlas Venture Associates Ix, LLC
- $11.3 Million
- Q3 2023
A detailed history of Atlas Venture Associates Ix, LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Atlas Venture Associates Ix, LLC holds 1,353,303 shares of SPRO stock, worth $3.26 Million. This represents 14.54% of its overall portfolio holdings.
Number of Shares
1,353,303
Previous 1,353,303
-0.0%
Holding current value
$3.26 Million
Previous $1.96 Million
16.56%
% of portfolio
14.54%
Previous 10.74%
Shares
2 transactions
Others Institutions Holding SPRO
# of Institutions
51Shares Held
10.6MCall Options Held
0Put Options Held
65.7K-
Vanguard Group Inc Valley Forge, PA1.99MShares$4.8 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.6MShares$3.86 Million0.5% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.45MShares$3.5 Million0.0% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$2.14 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA527KShares$1.27 Million0.0% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $84.5M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...